Cargando…

Human immunodeficiency virus-1 transgene expression increases pulmonary vascular resistance and exacerbates hypoxia-induced pulmonary hypertension development

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary arterial resistance and vessel remodeling. Patients living with human immunodeficiency virus-1 (HIV-1) have an increased susceptibility to develop severe pulmonary hypertension (PH) irrespective of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porter, Kristi M., Walp, Erik R., Elms, Shawn C., Raynor, Robert, Mitchell, Patrick O., Guidot, David M., Sutliff, Roy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641741/ https://www.ncbi.nlm.nih.gov/pubmed/23662175 http://dx.doi.org/10.4103/2045-8932.109915

Ejemplares similares

Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis
por: Wade, Brandy E., et al.
Publicado: (2018)

Chronic Hypoxia Promotes Pulmonary Artery Endothelial Cell Proliferation through H(2)O(2)-Induced 5-Lipoxygenase
por: Porter, Kristi M., et al.
Publicado: (2014)

Noninfectious Pulmonary Complications of Human Immunodeficiency Virus Infection
por: Staitieh, Bashar, et al.
Publicado: (2014)

NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation
por: Kwon, Min-Young, et al.
Publicado: (2018)

The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
por: Nisbet, Rachel E., et al.
Publicado: (2007)

HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension
por: Almodovar, Sharilyn, et al.
Publicado: (2020)

Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?
por: Green, David E., et al.
Publicado: (2011)

Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells
por: He, Qilian, et al.
Publicado: (2018)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction
por: Lassiter, Coy, et al.
Publicado: (2009)

Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats
por: Clary, Caroline R, et al.
Publicado: (2011)

The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension
por: Karoor, Vijaya, et al.
Publicado: (2021)

Human Immunodeficiency Virus and Pulmonary Arterial Hypertension
por: Mirrakhimov, Aibek E., et al.
Publicado: (2013)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
por: Sakao, Seiichiro, et al.
Publicado: (2014)

Tipifarnib prevents development of hypoxia-induced pulmonary hypertension
por: Duluc, Lucie, et al.
Publicado: (2017)

Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension
por: Li, Qian, et al.
Publicado: (2016)

Induced moderate hypothermia markedly exacerbates pulmonary hypertension and dysoxia in a neonatal piglet model of elevated pulmonary vascular resistance
por: Zayek, MM, et al.
Publicado: (2000)

Impact of human immunodeficiency virus on pulmonary vascular disease
por: Kumar, Ashok, et al.
Publicado: (2021)

Cavin-2 loss exacerbates hypoxia-induced pulmonary hypertension with excessive eNOS phosphorylation and protein nitration
por: Kasahara, Takeru, et al.
Publicado: (2023)

Hypoxia Mediates Mutual Repression between microRNA-27a and PPARγ in the Pulmonary Vasculature
por: Kang, Bum-Yong, et al.
Publicado: (2013)

24-Hour Hypoxia and Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
por: Rodrigues, Marcelo P., et al.
Publicado: (2017)

Pulmonary hypertension in chronic lung disease and hypoxia
por: Nathan, Steven D., et al.
Publicado: (2019)

Pulmonary hypertension and pulmonary vascular disease: course report
por: Peacock, Andrew, et al.
Publicado: (2018)

Updates in pulmonary hypertension and other pulmonary vascular diseases
por: Bernardo, Roberto J., et al.
Publicado: (2019)

Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats
por: Yu, Lunyin, et al.
Publicado: (2011)

Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats
por: Li, Xian-Wei, et al.
Publicado: (2015)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to lung diseases and/or hypoxia
por: Sakkijha, Husam, et al.
Publicado: (2014)

Effects of Intermittent Hypoxia on Pulmonary Vascular and Systemic Diseases
por: Kimura, Hiroshi, et al.
Publicado: (2019)

Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension
por: Roule, Vincent, et al.
Publicado: (2010)

Vorticity for the assessment of pulmonary vascular hemodynamics in pulmonary arterial hypertension
por: Honeyman, Alexander, et al.
Publicado: (2014)

Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility
por: Wallace, William D., et al.
Publicado: (2018)

The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
por: Lo, Charmaine C. W., et al.
Publicado: (2018)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
por: Leopold, Jane A., et al.
Publicado: (2016)

Upregulated Copper Transporters in Hypoxia-Induced Pulmonary Hypertension
por: Zimnicka, Adriana M., et al.
Publicado: (2014)

Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension
por: Yan, Lu, et al.
Publicado: (2020)

Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension
por: Granstam, Sven-Olof, et al.
Publicado: (2013)

Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells From the Rat SU5416/Hypoxia Model of Pulmonary Hypertension
por: Yun, Xin, et al.
Publicado: (2021)

Human immunodeficiency virus, herpes virus infections, and pulmonary vascular disease
por: Flores, Sonia C., et al.
Publicado: (2013)

Effects of paclitaxel intervention on pulmonary vascular remodeling in rats with pulmonary hypertension
por: Zhao, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gt6odtmk188jlnjl1h08v43tn4